Ketorolac on Posterior Thoracolumbar Spinal Fusions

PHASE4RecruitingINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

October 3, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions

Thoracolumbar Spinal Fusions

Interventions

DRUG

Saline

1 ml saline IV Q6H

DRUG

Ketorolac

15 mg (15 mg/ml) IV Q6H

Trial Locations (1)

RECRUITING

Providence-Providence Park, Southfield, Southfield

All Listed Sponsors

lead

Henry Ford Health System

OTHER